TN, Karnataka, Rajasthan declare highest number of NSQs in January: Gireesh Babu, New Delhi Saturday, February 28, 2026, 08:00 Hrs [IST] Around 29% of the total Not of Standard Qu ...

During a live event, Shaji Kumar, MD, discussed when talquetamab can be sequenced in multiple myeloma as an alternative to targeting BCMA in consecutive lines. Patients with relapsed/refractory ...

Sogroya® (somapacitan-beco) is a once-weekly treatment option, offering an alternative to once-daily therapy, which may help ...

DENVER -- A daily, single-tablet combination of bictegravir and lenacapavir (Yeztugo) was noninferior to complex multi-tablet ...

In a study published in the scientific journal Neurology in fall 2025, researchers found that consuming higher amounts of several common sugar substitutes was linked to accelerated cognitive decline ...

Walgreens is wading into the self-pay GLP-1 space, going head-to-head with telehealth subscription offerings. | Walgreens is wading into the self-pay GLP-1 space, going head-to-head with telehealth ...

TG Therapeutics reported $594M in 2025 U.S. BRIUMVI sales, a 90% YoY increase, and guides for $825–$850M in 2026. Click here ...

Tardigrades, commonly known as water bears, may be better suited by a new name: Tardiguardians of the Galaxy. Unlike the ...

Positive results from the aleniglipron Phase 2 ACCESS programs in December 2025 demonstrated significant weight loss across all doses and up to 15.3% at 36 weeks Topline 44-week data from the ACCESS ...

Data support emergence of differentiating clinical benefit with a favorable safety and tolerability profile for patients with ...

Onvuzosiran achieved significant and durable reductions of plasma kallikrein levels with a favorable safety profile in Phase 1/2 - ...